NanoEnTek (039860.KQ) Stock Price

NanoEnTek Price

CLOSED
4,455.00
​
Market closed

Revenue has compounded at 6.8% per year over the past 19 years to 38.13 B KRW. Earnings per share have declined at 16.8% per year over the last 16 years. NanoEnTek's net margin stands at 4.1%, down from 20.5% several years earlier.

NanoEnTek stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NanoEnTek business model & stock analysis

NanoEnTek Inc. manufactures and sells diagnostics and analytical equipment, including cell counting systems like Countess, EVE, and ADAM, gene delivery systems NEON, fluorescence microscopes JuLI, and consumable chips for cell counting. The company also offers diagnostic equipment such as FREND quantitative immunoassay analyzers and ADAM-rWBC for residual white blood cell counting in blood products. Products are sold domestically in Korea and internationally, targeting healthcare providers and biotechnology research institutions. The firm focuses on point of care testing (POCT) medical equipment and biotechnology research applications. NanoEnTek's revenue streams come from the sale of its branded equipment and consumables, with key products including Countess, EVE, ADAM, NEON, JuLI, and FREND systems. The company distributes these products to both domestic and overseas markets, serving customers in medical diagnostics and biotechnology research sectors. Sales of ADAM-rWBC devices for blood product analysis represent a specific segment of their diagnostic equipment portfolio. The business model relies on direct sales of medical and biotechnology equipment, with no mention of subscription services or additional revenue sources. Products are categorized by their application: cell counting, gene delivery, microscopy, and diagnostic analysis, each with dedicated branded systems. The company's focus on POCT and biotechnology research equipment differentiates its offerings in the medical device market.

Frequently asked questions about NanoEnTek

Converted at the current exchange rate, the NanoEnTek share trades at 2.96 EUR (4,455.00 KRW).

The revenue cannot currently be calculated for NanoEnTek.

The profit cannot currently be calculated for NanoEnTek.

The P/E ratio cannot be calculated for NanoEnTek at the moment.

The P/S cannot be calculated for NanoEnTek currently.

The Eulerpool Quality Score for NanoEnTek is 2/10.

The ISIN of NanoEnTek is KR7039860002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of NanoEnTek is 039860.KQ. The ticker symbol is used to trade NanoEnTek shares on the stock exchange.

Fair ValueTerminal
4,009.50 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Aug 16, 2000
ISIN
KR7039860002
Cusip
Y2677Y106
Market capitalization
133.92 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
121.58
P/B Ratio
1.47
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1.74 %
Last updated Nov 3, 2026, 3:43 AM

NanoEnTek Peer Group

NanoEnTek FIGI

039860:KS · BBG000BCGGN2039860:KQ · BBG000BCGJB9

All fundamentals and in-depth analysis of NanoEnTek

Our stock analysis for NanoEnTek stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NanoEnTek. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.